Overview
Chemical company's Q4 net sales rose 16%, beating analyst expectations
Adjusted loss per share for Q4 missed analyst expectations
Adjusted EBITDA for Q4 increased 7%, beating analyst estimates
Outlook
Albemarle projects 2026 capital expenditures to be approximately flat year-over-year
Company anticipates meaningful free cash flow generation with higher lithium prices
Albemarle expects to close Ketjen stake sale in Q1 2026
Result Drivers
ENERGY STORAGE GROWTH - Energy Storage segment net sales rose 23% due to higher volumes and pricing
KETJEN SALES INCREASE - Ketjen segment net sales increased 14% driven by higher FCC volumes and favorable product mix
COST AND PRODUCTIVITY IMPROVEMENTS - Achieved $450 mln in cost and productivity improvements, exceeding initial targets
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Net sales | Beat | $1.43 bln | $1.35 bln (16 Analysts) |
Q4 Adjusted EPS | Miss | -$0.53 | -$0.41 (18 Analysts) |
Q4 EPS | -$3.87 | ||
Q4 Adjusted EBITDA | Beat | $268.70 mln | $239.47 mln (17 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Albemarle Corp is $185.00, about 9.8% above its February 10 closing price of $168.56
Press Release: ID:nPn30DJKJa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)